C26H41N3O7S2 — CID 163513183
(3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-5,9-dioxo-4-oxa-17-azabicyclo[14.1.0]heptadecane-17-sulfonamide (PubChem CID 163513183) has the molecular formula C26H41N3O7S2 and a molecular weight of 571.76 g/mol. Its IUPAC name is (3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-5,9-dioxo-4-oxa-17-azabicyclo[14.1.0]heptadecane-17-sulfonamide.
| Compound Name | (3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-5,9-dioxo-4-oxa-17-azabicyclo[14.1.0]heptadecane-17-sulfonamide |
|---|---|
| PubChem CID | 163513183 |
| Molecular Formula | C26H41N3O7S2 |
| Molecular Weight | 571.76 g/mol |
| Exact Mass | 571.24 |
| IUPAC Name | (3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12-tetramethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-5,9-dioxo-4-oxa-17-azabicyclo[14.1.0]heptadecane-17-sulfonamide |
| SMILES | C/C(=C\c1csc(C)n1)[C@@H]1CC2[C@@H](CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)N2S(N)(=O)=O |
| InChI | InChI=1S/C26H41N3O7S2/c1-14-8-7-9-19-20(29(19)38(27,34)35)11-21(15(2)10-18-13-37-17(4)28-18)36-23(31)12-22(30)26(5,6)25(33)16(3)24(14)32/h10,13-14,16,19-22,24,30,32H,7-9,11-12H2,1-6H3,(H2,27,34,35)/b15-10+/t14-,16+,19+,20?,21-,22-,24-,29?/m0/s1 |
| InChIKey | DELGITAISRCIDM-YKLNYMLCSA-N |
| XLogP | 2.58 |
| TPSA | 159.89 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 38 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 571.76 |
| LogP ≤ 5 | 2.58 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|